Anticoagulant-induced changes on antibiotic concentrations in the serum and bones

Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of drug metabolism and pharmacokinetics 2008-07, Vol.33 (3), p.173-179
Hauptverfasser: Kotsiou, A., Diamanti, E., Potamianou, A., Parara, H., Vovou, J., Perisanidis, C., Tesseromatis, C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 179
container_issue 3
container_start_page 173
container_title European journal of drug metabolism and pharmacokinetics
container_volume 33
creator Kotsiou, A.
Diamanti, E.
Potamianou, A.
Parara, H.
Vovou, J.
Perisanidis, C.
Tesseromatis, C.
description Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14 g were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin via 1 g/kg/8h im injection. Group II received cefapirin via of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.
doi_str_mv 10.1007/BF03191115
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03191115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19007043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</originalsourceid><addsrcrecordid>eNpt0M9PwyAUB3BiNG6Zu_gHGC5eNNVHKaU9zsVfyRJjoucGXunGssEC7cH_XpYt7iIXkscHHu9LyDWDBwYgH59egLOaMSbOyDhnIDNgFZyTMXBZZbIuyxGZxriGtHhVC1FekhGr01Uo-Jh8zlxv0avlsFGuz6xrBzQtxZVySxOpdzSVrbY-KYreoXF9UL31LlLraL8yNJowbBNrqfbOxCty0alNNNPjPiHfL89f87ds8fH6Pp8tMuQM-gzLSkmDneFFW-nWAOj0eyM7jSIv6lIhMqNFqkKJhZZ1GhJk3iVh8koUfELuDu9i8DEG0zW7YLcq_DQMmn00zSmahG8OeDforWlP9BhEArdHoCKqTReUQxv_XA6yKgXfu_uDi-koRRSatR-CS4P-1_YXN8p5EA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</creator><creatorcontrib>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</creatorcontrib><description>Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14 g were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin via 1 g/kg/8h im injection. Group II received cefapirin via of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</description><identifier>ISSN: 0378-7966</identifier><identifier>EISSN: 2107-0180</identifier><identifier>DOI: 10.1007/BF03191115</identifier><identifier>PMID: 19007043</identifier><language>eng</language><publisher>Paris: Springer-Verlag</publisher><subject>Acenocoumarol - pharmacology ; Administration, Oral ; Animals ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Anticoagulants - pharmacology ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Drug Interactions ; Femur - chemistry ; Human Physiology ; Injections, Intramuscular ; Male ; Mandible - chemistry ; Medical Biochemistry ; Medical sciences ; Pharmaceutical Sciences/Technology ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacy ; Prothrombin Time ; Quinolones - blood ; Quinolones - pharmacokinetics ; Rats ; Rats, Wistar ; Tissue Distribution</subject><ispartof>European journal of drug metabolism and pharmacokinetics, 2008-07, Vol.33 (3), p.173-179</ispartof><rights>Springer-Verlag 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/BF03191115$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/BF03191115$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20786533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19007043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kotsiou, A.</creatorcontrib><creatorcontrib>Diamanti, E.</creatorcontrib><creatorcontrib>Potamianou, A.</creatorcontrib><creatorcontrib>Parara, H.</creatorcontrib><creatorcontrib>Vovou, J.</creatorcontrib><creatorcontrib>Perisanidis, C.</creatorcontrib><creatorcontrib>Tesseromatis, C.</creatorcontrib><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><title>European journal of drug metabolism and pharmacokinetics</title><addtitle>Eur. J. Drug Metabol. Pharmacokinet</addtitle><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><description>Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14 g were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin via 1 g/kg/8h im injection. Group II received cefapirin via of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</description><subject>Acenocoumarol - pharmacology</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anticoagulants - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Drug Interactions</subject><subject>Femur - chemistry</subject><subject>Human Physiology</subject><subject>Injections, Intramuscular</subject><subject>Male</subject><subject>Mandible - chemistry</subject><subject>Medical Biochemistry</subject><subject>Medical sciences</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Prothrombin Time</subject><subject>Quinolones - blood</subject><subject>Quinolones - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Tissue Distribution</subject><issn>0378-7966</issn><issn>2107-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0M9PwyAUB3BiNG6Zu_gHGC5eNNVHKaU9zsVfyRJjoucGXunGssEC7cH_XpYt7iIXkscHHu9LyDWDBwYgH59egLOaMSbOyDhnIDNgFZyTMXBZZbIuyxGZxriGtHhVC1FekhGr01Uo-Jh8zlxv0avlsFGuz6xrBzQtxZVySxOpdzSVrbY-KYreoXF9UL31LlLraL8yNJowbBNrqfbOxCty0alNNNPjPiHfL89f87ds8fH6Pp8tMuQM-gzLSkmDneFFW-nWAOj0eyM7jSIv6lIhMqNFqkKJhZZ1GhJk3iVh8koUfELuDu9i8DEG0zW7YLcq_DQMmn00zSmahG8OeDforWlP9BhEArdHoCKqTReUQxv_XA6yKgXfu_uDi-koRRSatR-CS4P-1_YXN8p5EA</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Kotsiou, A.</creator><creator>Diamanti, E.</creator><creator>Potamianou, A.</creator><creator>Parara, H.</creator><creator>Vovou, J.</creator><creator>Perisanidis, C.</creator><creator>Tesseromatis, C.</creator><general>Springer-Verlag</general><general>Médecine et hygiène</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080701</creationdate><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><author>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acenocoumarol - pharmacology</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anticoagulants - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Drug Interactions</topic><topic>Femur - chemistry</topic><topic>Human Physiology</topic><topic>Injections, Intramuscular</topic><topic>Male</topic><topic>Mandible - chemistry</topic><topic>Medical Biochemistry</topic><topic>Medical sciences</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Prothrombin Time</topic><topic>Quinolones - blood</topic><topic>Quinolones - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kotsiou, A.</creatorcontrib><creatorcontrib>Diamanti, E.</creatorcontrib><creatorcontrib>Potamianou, A.</creatorcontrib><creatorcontrib>Parara, H.</creatorcontrib><creatorcontrib>Vovou, J.</creatorcontrib><creatorcontrib>Perisanidis, C.</creatorcontrib><creatorcontrib>Tesseromatis, C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kotsiou, A.</au><au>Diamanti, E.</au><au>Potamianou, A.</au><au>Parara, H.</au><au>Vovou, J.</au><au>Perisanidis, C.</au><au>Tesseromatis, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</atitle><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle><stitle>Eur. J. Drug Metabol. Pharmacokinet</stitle><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>33</volume><issue>3</issue><spage>173</spage><epage>179</epage><pages>173-179</pages><issn>0378-7966</issn><eissn>2107-0180</eissn><abstract>Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14 g were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin via 1 g/kg/8h im injection. Group II received cefapirin via of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</abstract><cop>Paris</cop><pub>Springer-Verlag</pub><pmid>19007043</pmid><doi>10.1007/BF03191115</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-7966
ispartof European journal of drug metabolism and pharmacokinetics, 2008-07, Vol.33 (3), p.173-179
issn 0378-7966
2107-0180
language eng
recordid cdi_crossref_primary_10_1007_BF03191115
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Acenocoumarol - pharmacology
Administration, Oral
Animals
Anti-Bacterial Agents - blood
Anti-Bacterial Agents - pharmacokinetics
Anticoagulants - pharmacology
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Drug Interactions
Femur - chemistry
Human Physiology
Injections, Intramuscular
Male
Mandible - chemistry
Medical Biochemistry
Medical sciences
Pharmaceutical Sciences/Technology
Pharmacology. Drug treatments
Pharmacology/Toxicology
Pharmacy
Prothrombin Time
Quinolones - blood
Quinolones - pharmacokinetics
Rats
Rats, Wistar
Tissue Distribution
title Anticoagulant-induced changes on antibiotic concentrations in the serum and bones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T11%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticoagulant-induced%20changes%20on%20antibiotic%20concentrations%20in%20the%20serum%20and%20bones&rft.jtitle=European%20journal%20of%20drug%20metabolism%20and%20pharmacokinetics&rft.au=Kotsiou,%20A.&rft.date=2008-07-01&rft.volume=33&rft.issue=3&rft.spage=173&rft.epage=179&rft.pages=173-179&rft.issn=0378-7966&rft.eissn=2107-0180&rft_id=info:doi/10.1007/BF03191115&rft_dat=%3Cpubmed_cross%3E19007043%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19007043&rfr_iscdi=true